FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)
FRACTION:德国 MPN 研究组 (GSG-MPN) 开展的 Fedratinib 和 Nivolumab 联合治疗骨髓纤维化且对 JAK 抑制剂治疗耐药或反应欠佳患者的 II 期研究方案
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-024-05867-w
Isfort, Susanne; von Bubnoff, Nikolas; Al-Ali, Haifa Kathrin; Becker, Heiko; Götze, Thorsten; le Coutre, Philipp; Griesshammer, Martin; Moskwa, Claudia; Wohn, Luisa; Riedel, Johanna; Palandri, Francesca; Manz, Kirsi; Hochhaus, Andreas; Döhner, Konstanze; Heidel, Florian H